VEGFB and neoplasm: Results showed that the expression of ADAM17 was mutually exclusive of several tumor immune checkpoints, like CD40LG, CX3CL1, VEGFB, TNFSF9, IFNA2 in ESCA, STES, LAML, DLBC, UVM, THYM, KIRP, LGG or GBMLGG (Figure 6A).